Preclinical Dutch biotech developing an mRNA repair therapy for cystic fibrosis.
Industry: Health Care
First Day Return: +13.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/14/2014 |
Offer Price | $13.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $98 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/17/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $98 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Leiden, Netherlands |
Founded | 2012 |
Employees at IPO | 45 |
Website www.proqr-tx.com |